Uncategorized

VIDEO: Surgeon updates Jetrea clinical safety

by Healio ophthalmology • 2015/01/26 • 0 Comments

WAILEA, Hawaii – At Hawaiian Eye 2015, Peter Kaiser, MD, discusses the safety coniderations for patients undergoing ocriplasmin (Jetrea, Thrombogenics) for vitreomacular disease.

Full Story →

← Eye health could help diagnose people with chronic fatigue syndrome

PDT should be considered for chronic central serous chorioretinopathy →

Post navigation